Plasmid-mediated quinolone resistance;Résistance plasmidique aux quinolones

Antibiotiques

Volumn 9, Issue 4, 2007, Pages 246-253

  Nordmann, P ^a   Mammeri, H ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Fluoroquinolones; High level low level resistance; Markers QnrA; Plasmid borne resistance; QnrB; QnrS

Indexed keywords

ACYLTRANSFERASE; AMINOGLYCOSIDE; CIPROFLOXACIN; DNA; DNA TOPOISOMERASE; NORFLOXACIN; PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BINDING AFFINITY; CHEMICAL STRUCTURE; CHROMOSOME; DISEASE PREDISPOSITION; ENTEROBACTER; ENZYME SPECIFICITY; EXPERIENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; REGULATORY MECHANISM;

EID: 37249083902     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1294-5501(07)73921-3     Document Type: Article

References (67)

1. BALL P. Quinolone generations: natural history or natural selection ? J Antimicrob Chemother 2000 ; 46 : 17-24.
2. NEUHAUSER MM, WEINSTEIN RA, RYDMAN R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fl uoroquinolone use. JAMA 2003 ; 289 : 885-8.
3. LING TK, XIONG J, YU Y, et al. Multicenter antimicrobial susceptibility survey of Gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother 2006 ; 50 : 374-8.
4. HOOPER DC. Mechanisms of quinolone resistance. In : HOOPER DC, RUBENSTEIN E, editors. Quinolone antimicrobial agents. 3rd edition. Washington, DC : American Society for Microbiology Press ; 2003. p. 41-67.
5. POOLE K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005 ; 56 : 20-51.
6. RUIZ J. Mechanisms of resistance to quinolones : target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003 ; 51 : 1109-17.
7. MARTINEZ-MARTINEZ L, PASCUAL A, JACOBY GA. Quinolone resistance from a transferable plasmid. Lancet 1998 ; 351 : 797-9.
8. TRAN JH, JACOBY GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002 ; 99 : 5638-42.
9. WANG M, TRAN JH, JACOBY GA, et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003 ; 47 : 2242-8.
10. WANG M, SAHM DF, JACOBY GA, et al. Emerging plasmid mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 2004 ; 48 : 1295-99.
11. MAMMERI H, VAN DE LOO, POIREL L, et al. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005 ; 49 : 71-6.
12. LI JB, YU YS, MA YL, et al. Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui, China. Infection 2001 ; 29 : 228-31.
13. CHEUNG TK, CHU YW, CHU MY et al. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother 2005 ; 56 : 586-9.
14. HATA M, SUZUKI M, MATSUMOTO M, et al. Cloning of a novel quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005 ; 49 : 773-5.
15. GAY K, ROBICSEK A, STRAHILEVITZ J, et al. Plasmid mediated quinolone resistance in non-Typhi Salmonella. Clin Infect Dis 2006 ; 43 : 297-304.
16. JACOBY GA, WALSH KE, MILLS DM, et al. qnrB, another plasmid mediated gene for quinolone resistance. Antimicrob Agents Chemother 2006 ; 50 : 1178-82.
17. ROBICSEK A, STRAHILEVITZ J, SAHM DF, et al. qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006 ; 50 : 2872-74.
18. VETTING MW, HEGDE SS, FAJARDO JE, et al. Pentapeptide repeat proteins. Biochemistry 2006 ; 45 : 1-10.
19. HEDDLE JG, BLANCE SJ, ZAMBLE DB, et al. The antibiotic microcinB17 is a DNA gyrase poison: characterisation of the mode of inhibition. J Mol Biol 2001 ; 307 : 1223-34.
20. GARRIDO MC, HERRERO M, KOLTER R, et al. The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J 1988 ; 7 : 1853-62.
21. JACOBY GA, CHOW N, WAITES KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 2003 ; 47 : 559-62.
22. MONTERO C, MATEU G, RODRIGUEZ R, et al. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother 2001 ; 45 : 3387-92.
23. HEGDE SS, VETTING MW, RODERICK SL, et al. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 2005 ; 308 : 1480-3.
24. TRAN JH, JACOBY GA, HOOPER DC. Interaction of the plasmid encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 2005 ; 49 : 118-25.
25. TRAN JH, JACOBY GA, HOOPER DC. Interaction of the plasmid encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother 2005 ; 49 : 3050-2.
26. CAVALLO JD, CHARDON H, CHIDIAC C, et al. Communiqué de 2006. Comité de l'Antibiogramme de la Société Française de Microbiologie ; 2007 ; Paris, France.
27. WANG M, SAHM DF, JACOBY GA, et al. Activities of newer quinolones against Escherichia coliand Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 2004 ; 48 :1400-1.
28. ROBICSEK A, SAHM DF, STRAHILEVITZ J, et al. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother 2005 ; 49 : 3001-3.
29. MAMMERI H, POIREL L, NORDMANN P. Bactericidal activity of fluoroquinolones against plasmid-mediated QnrA-producing Escherichia coli. Clin Microbiol Infect 2005 ; 11 : 1048-9.
30. CANO ME, MARTINEZ-MARTINEZ L, GARCIA-LOBO JM et al. Detection of orf513 and qnrA among multiresistant Gram-negative clinical isolates in Spain. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy ; 2005 Dec 16-19 ; Washington, DC, USA. Abstract C1-1043.
31. CANO ME, RODRIGUEZ-MARTINEZ JM, AGUERO J, et al. Detection of qnrSin clinical isolates of Enterobacter cloacae in Spain. 16th European Congress of Clinical Microbiology and Infectious Diseases ; 2006 April 1-4 ; Nice, France. Abstract O52.
32. CORKILL JE, ANSON JJ, HART CA. High prevalence of the plasmid mediated quinolone resistance determinant qnrAin multidrug resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother 2005 ; 56 : 1115-7.
33. JEONG JY, YOON HJ, KIM ES, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 2005 ; 49 : 2522-4.
34. JUN J, KWAK Y, KIM S, et al. Prevalence of plasmid-mediated quinolone resistance in clinical isolates of Enterobacter cloacae from Korea. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy ; Washington, DC, USA ; Dec 16-19 2005. Abstract C2-787.
35. JONAS D, BIEHLER K, HARTUNG D, et al. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob Agents Chemother2005 ; 49 : 773-5.
36. MINARINI LAR, GALES AC, DARINI ALC. First report of plasmid-mediated resistance to quinolones and cefotaxime in an Enterobacter cloacae strain isolated from an outpatient in Brazil. Antimicrob Agents Chemother 2007 ; 51 : 401-2.
37. NAZIC H, POIREL L, NORDMANN P. Further identification of plasmid mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother 2005 ; 49 : 2146-7.
38. PAAUW A, FLUIT AC, VERHOEF J, et al. Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital. Emerg Infect Dis2006 ; 12 : 807-12.
39. POIREL L, VAN DE LOO M, MAMMERI H, et al. Association of plasmid-mediated quinolone resistance with extended-spectrum β-lactamase VEB-1. Antimicrob Agents Chemother 2005 ; 49 : 3091-4.
40. POIREL L, PITOUT JD, CALVO L, et al. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother 2006 ; 50 : 1525-7.
41. RODRIGUEZ-MARTINEZ JM, PASCUAL A, GARCIA I, et al. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. J Antimicrob Chemother 2003 ; 52 : 703-6.
42. RODRIGUEZ-MARTINEZ JM, POIREL L, PASCUAL A, et al. Plasmid mediated quinolone resistance in Australia. Microb Drug Resist 2006 ; 12 : 99-102.
43. SCHULTSZ C, YEN LM, LINH LD, et al. High prevalence of qnrS and qnrA genes among Enterobacteriaceae on an ICU in Ho Chi Minh City, Viet Nam. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy ; Washington, DC, USA ; Dec 16-19 2005. Abstract LB-22.
44. SOGE OO, ADENIYI BA, ROBERTS MC. New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 2006 ; 58 :1048-53.
45. WANG M, YE X, WU S, et al. Prevalence of the plasmid mediated quinolone resistance determinant qnrA among consecutive clinical strains isolated from a teaching hospital in Shanghai, China. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy ; Washington, DC, USA ; Dec 16-19 2005. Abstract C2-785.
46. WIEGAND I, KHALAF N, AL-AGAMY MHM, et al. First detection of the transferable quinolone resistance in clinical Providencia stuartii strains in Egypt. Clin Microbiol Infect2004 ; 10 (suppl 3) :64.
47. WU JJ, KO WC, TSAI SH, et al. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 2007 ; 51 :1223-7.
48. HENRICHFREISE B, PFISTER W, WIEGAND I, et al. Resistance mechanisms and epidemiology of multiresistant Pseudomonas aeruginosa strains from Germany. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy ; Washington, DC, USA ; Dec 16-19 2005. Abstract C2-1423.
49. LAVIGNE JP, MARCHANDIN H, DELMAS J, et al. qnrA in CTX-M-Producing Escherichia coli Isolates from France. Antimicrob Agents Chemother 2006 ; 50 : 4224-8.
50. CHU YW, CHEUNG TK, NG TK, et al. Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 2000-2005 in Hong Kong. J Antimicrob Chemother 2006 ; 58 :904-5.
51. GARNIER F, RAKED N, GASSAMA A, et al. Genetic Environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica Serovar Keurmassar. Antimicrob Agents Chemother 2006 ; 50 : 3200-2.
52. POIREL L, CATTOIR V, SOARES A, et al. Characterization of the novel Ambler class A β-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance QnrS1 determinant. Antimicrob Agents Chemother 2007 ; 51 : 631-7.
53. BÖNEMANN G, STIENS M, PÜHLER A, et al. Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant. Antimicrob Agents Chemother 2006 ; 50 : 3075-80.
54. POIREL L, LEVIANDIER C, NORDMANN P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a french university hospital. Antimicrob Agents Chemother 2006 ; 50 : 3992-7.
55. POIREL L, RODRIGUEZ-MARTINEZ JM, MAMMERI H, et al. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 2005 ; 49 : 3523-5.
56. FONNESBECH-VOGEL B, HOLT HM, GERNER-SMIDT P et al. Homogeneity of Danish environmental and clinical isolates of Shewanella algae. Appl Environ Microbiol 2000 ; 66 : 443-8.
57. PAGNIEZ H, BERCHE P. Oppotunistic infections caused by Shewanella, new emergent bacteria. Med Mal Infect 2005 ; 35 : 186-91.
58. BEABER JW, HOCHHUT B, WALDOR MK. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004 ; 427 : 72-4.
59. NORM/NORM-VET2002. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromso/Oslo 2003. ISSN : 1502-2307. p. 13.
60. POIREL L, LIARD A, RODRIGUEZ-MARTINEZ JM, et al. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J Antimicrob Chemother 2005 ; 56 : 1118-21.
61. SAGA T, KAKU M, ONODERA Y, et al. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli. Antimicrob Agents Chemother 2005 ; 49 :2144-5.
62. CATTOIR V, POIREL L, MAZEL D, et al. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother 2007 ; 51 : 2650-1.
63. HALL RM, STOKES HW. The structure of a partial duplication in the integron of plasmid pDGO100. Plasmid 1990 ; 23 : 76-9.
64. st century? Mic Mol Biol Rev 2006 ; 70 : 296-316.
65. ROBICSEK A, STRAHILEVITZ J, JACOBY GA, et al. Fluoroquinolone modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med2006 ; 12 : 83-8.
66. PARK CH, ROBICSEK A, JACOBY GA, et al. Prevalence of aac(6')Ib-crencoding a ciprofloxacin-modifying enzyme in the United States. Antimicrob Agents Chemother 2006 ; 50 : 3953-5.
67. CATTOIR V. POIREL L, ROTIMI V, et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007 ; 60 : 394-7.